Introduction:

Holmium Laser Enucleation of the Prostate (HoLEP) is an endoscopic surgical technique used to treat obstructive prostatic enlargement. Currently, the guidelines of the American Urological Association and the European Association of Urology consider HoLEP a surgical treatment alternative to TURP (Transurethral Resection of the Prostate) and open prostatectomy.

Materials and Methods:

An observational, descriptive, cross-sectional retrospective prevalence study was conducted from 2022 to 2024. Results: Data from 182 patients who underwent HoLEP at the La Costa Medical Center by the same surgical team were analyzed. The mean age of the operated patients was 66.59 years. The mean prostate size was 77.10. The average surgical time was 99.8 minutes. Regarding complications, there was a 2.7% rate of reintervention due to hematuria, 1% of patients required blood transfusion, and 1.6% of patients experienced episodes of acute urinary retention after catheter removal, resulting in an overall complication rate of 5.5%.

Conclusion:

Prostate gland enlargement is a natural event of male aging. Among the valid therapeutic alternatives, HoLEP is an option regardless of prostate size. It is currently considered the gold standard in the surgical management of the prostate gland. Our aim is to present the first cases described in our country with results comparable to those described in the global medical literature.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )